Indication
Seasonal Allergic Rhinitis
3 clinical trials
7 products
Clinical trial
Grass Pollen Sublingual Tablet Immunotherapy Plus Dupilumab for Induction of Tolerance in Adults With Moderate to Severe Seasonal Allergic Rhinitis (ITN084AD)Status: Active (not recruiting), Estimated PCD: 2025-01-01
Product
Dupixent®Product
Grazax®Product
DupixentProduct
GrazaxClinical trial
Immunological Analysis of Lymph Node Tissue After Intralymphatic Immunotherapy: A Prospective Case Control StudyStatus: Active (not recruiting), Estimated PCD: 2024-05-07
Product
Polvac Grass+RyeClinical trial
Is the Effect of Systemic Steroids Treating Pollen Induced Allergic Rhinitis Mainly Due to a Placebo EffectStatus: Completed, Estimated PCD: 2022-06-20
Product
MethylPREDNISoloneProduct
NaCl